Wegovy Q3 sales total $2.5 bln Beat forecast but group sales weaker than expected Results soothe investor worries over slowing obesity drug demand Shares rose nearly 9%, but later reversed course ...

Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing results three months ago. GLP-1 agonist Wegovy ...

Novo Nordisk A/S shares rose as surging sales of the blockbuster weight-loss treatment Wegovy reassured investors after rival ...

Novo Nordisk (NVO) reported mixed earnings for the third quarter of 2024 but beat Wall Street revenue expectations for its blockbuster weight-loss drug, Wegovy. Novo announced an earnings per ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

The 2024/25 UEFA Conference League season will conclude at Stadion Wrocław in Wroclaw, Poland, bringing an end to another adventure that encourages fresh talent to flourish. The home of two-time ...

The UEFA Conference League is enabling rising talents from across the continent to thrive. The competition is available to watch across Europe and throughout the world thanks to UEFA's official ...

The Aam Aadmi Party is intensifying its efforts for the upcoming Delhi Assembly elections by organizing a conference for district and booth-level office bearers starting November 11. Arvind Kejriwal's ...

Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring investors worried that demand was slowing and it could lose the race in the ...

Today's Pets of the Day are Shelly and Isla. They are available from Angels Among Us. She’s the voice behind some of the biggest hits in pop music history. And this weekend, her story is playing ...